| 0 | 💬 0 |
Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-04 | #vaccination #clinical trial #rna #immunogenicity #rsv |